SEC Form 4 · accession 0001179110-18-003331
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura J Schumacher
Officer — Executive Vice President
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par value | Feb 28, 2018 | F | 27,835 | $118.26 | D | 123,317 | D | |
| Common stock, $0.01 par value | Mar 1, 2018 | S | 25,000 | $117.8459 | D | 98,317 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).